annual cash & cash equivalents:
$31.68M-$56.48M(-64.07%)Summary
- As of today (September 20, 2025), BLTE annual cash & cash equivalents is $31.68 million, with the most recent change of -$56.48 million (-64.07%) on December 31, 2024.
- During the last 3 years, BLTE annual cash & cash equivalents has risen by +$14.33 million (+82.64%).
- BLTE annual cash & cash equivalents is now -64.07% below its all-time high of $88.16 million, reached on December 31, 2023.
Performance
BLTE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$149.20M-$8.20M(-5.21%)Summary
- As of today (September 20, 2025), BLTE quarterly cash & cash equivalents is $149.20 million, with the most recent change of -$8.20 million (-5.21%) on June 30, 2025.
- Over the past year, BLTE quarterly cash & cash equivalents has increased by +$36.90 million (+32.86%).
- BLTE quarterly cash & cash equivalents is now -5.21% below its all-time high of $157.40 million, reached on March 31, 2025.
Performance
BLTE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLTE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.1% | +32.9% |
| 3 y3 years | +82.6% | - |
| 5 y5 years | +23.6% | +760.2% |
BLTE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.1% | +82.6% | -5.2% | +294.7% |
| 5 y | 5-year | -64.1% | +82.6% | -5.2% | +760.2% |
| alltime | all time | -64.1% | +82.6% | -5.2% | +760.2% |
BLTE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $149.20M(-5.2%) |
| Mar 2025 | - | $157.40M(+8.4%) |
| Dec 2024 | $31.68M(-64.1%) | $145.15M(+33.2%) |
| Sep 2024 | - | $109.00M(-2.9%) |
| Jun 2024 | - | $112.30M(+17.6%) |
| Mar 2024 | - | $95.50M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $88.16M(+109.5%) | $88.16M(+61.8%) |
| Sep 2023 | - | $54.50M(-5.1%) |
| Jun 2023 | - | $57.40M(+51.9%) |
| Mar 2023 | - | $37.80M(-10.2%) |
| Dec 2022 | $42.09M(+142.7%) | $42.09M(+142.7%) |
| Dec 2021 | $17.34M(-32.3%) | $17.34M |
| Dec 2020 | $25.62M | - |
FAQ
- What is Belite Bio, Inc annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Belite Bio, Inc?
- What is Belite Bio, Inc annual cash & cash equivalents year-on-year change?
- What is Belite Bio, Inc quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Belite Bio, Inc?
- What is Belite Bio, Inc quarterly cash & cash equivalents year-on-year change?
What is Belite Bio, Inc annual cash & cash equivalents?
The current annual cash & cash equivalents of BLTE is $31.68M
What is the all time high annual cash & cash equivalents for Belite Bio, Inc?
Belite Bio, Inc all-time high annual cash & cash equivalents is $88.16M
What is Belite Bio, Inc annual cash & cash equivalents year-on-year change?
Over the past year, BLTE annual cash & cash equivalents has changed by -$56.48M (-64.07%)
What is Belite Bio, Inc quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BLTE is $149.20M
What is the all time high quarterly cash & cash equivalents for Belite Bio, Inc?
Belite Bio, Inc all-time high quarterly cash & cash equivalents is $157.40M
What is Belite Bio, Inc quarterly cash & cash equivalents year-on-year change?
Over the past year, BLTE quarterly cash & cash equivalents has changed by +$36.90M (+32.86%)